F0392
Fetal Bovine Serum
USA origin, Dialyzed by ultrafiltration against 0.15 M NaCl, sterile-filtered, suitable for cell culture
Synonym(s):
Fetal Bovine Sera, Fetal Calf Sera, FBS, FCS, sera, serum
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Biological source:
bovine fetus
Origin:
USA origin
Sterility:
sterile-filtered
Form:
liquid
Shipped in:
dry ice
biological source
bovine fetus
Quality Level
sterility
sterile-filtered
product line
FBS Select
form
liquid
composition
Bovine IgG, ≤1 mg/mL , Hemoglobin, ≤20 mg/dL
origin
USA origin
technique(s)
cell culture | mammalian: suitable
impurities
≤10 EU/mL endotoxin
shipped in
dry ice
storage temp.
−20°C
Application
Fetal Bovine Serum has been used as a supplement for various cell culture techniques as it provides many non-defined growth promoting and survival enhancing factor to cells in culture.
Biochem/physiol Actions
Fetal Bovine Serum (FBS) is a constituent of animal cell culture media. It contains hormones and growth factors. FBS promotes in vitro cell culture, by providing binding proteins, lipids, minerals, attachment and spreading factors.
Preparation Note
10,000 Molecular Weight Cut-off
Analysis Note
- Endotoxin and hemoglobin tested
- Tested for the presence of bacteria, virus, and mycoplasma
- Triple filtered with 0.1 micron membrane under aseptic conditions
Still not finding the right product?
Explore all of our products under Fetal Bovine Serum
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
The use of fetal bovine serum: ethical or scientific problem?
Jochems CEA, et al.
Alternatives to Laboratory Animals : ATLA, 30(2), 219-227 (2002)
Liver Tissue Engineering Based on Poly (ethylen Glycol) Hydrogels (2010)
Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs
Saqcena M, et al.
Oncogene, 34(20), 2672-2672 (2015)